2C-N Stats & Data

Evidence-based harm-reduction additions and corrections (reasoning and citations below): 1) Dosage correction: PIHKAL associates 2C‑N with much higher oral doses than originally listed. Community bioassays report noticeable to fully psychedelic effects at ~100–130 mg (HCl salt), with 60 mg nitrate described as mild. The prior 8–30 mg range risks underdosing and confusing 2C‑N with far more potent NBOMe analogs; corrected to 90–130 mg common range with conservative lower bands. 2) Salt-form potency: One Erowid report explicitly notes the nitrate salt is ~9% less potent than HCl; while anecdotal, users should account for salt mass when weighing. 3) Short duration: Reports consistently describe a shorter total timeline (≈3–5 hours at typical doses), so duration was tightened to 3–6 hours with rapid onset at higher doses. 4) Interaction specifics: TripSit’s combination guidance for 2C‑x supports listing MAOIs as ‘dangerous’, tramadol as ‘unsafe’ (seizure risk), and stimulants/caffeine as cautionary due to cardiovascular and anxiety load; SSRIs/SNRIs may attenuate or unpredictably alter effects. 5) Insufflation caution: Across 2C‑x, insufflation is commonly very painful with greater side effects; oral dosing is strongly preferred for safety and comfort. 6) Misidentification risk: 2C‑N is rare; NBOMes/NBOHs on blotter or as potent sub‑mg powders are sometimes sold as ‘2C‑x’. NBOMes are active at microgram doses and have been linked to medical emergencies; always test and avoid unknown blotters as ‘2C‑N’. 7) Legal risk (U.S.): 2C‑N was added to Schedule I in July 2012, creating substantial legal penalties for possession/distribution. 8) Tolerance: Classic 5‑HT2A psychedelics rapidly produce tolerance within days with cross‑tolerance across LSD/psilocybin/mescaline/DOx; spacing uses by ~10–14 days reduces unpredictable responses. 9) Phenethylamine body load: Some users report mild GI upset, stimulation, or vasoconstriction; avoid combining with vasoconstrictive stimulants and monitor hydration and temperature. 10) Data scarcity: Human data are limited; individual variability is high; start low, weigh accurately, and prefer oral administration.